Javascript Menu by Deluxe-Menu.com

SKNBuzz Radio - Strictly Local Music Toon Center
My Account | Contact Us  
 Home  >  Headlines  >  NEWS
Posted: Friday 24 September, 2021 at 9:16 PM

CMO Laws confident that vaccination status of locals will be recognized by the UK and US

Covishield Oxford-Astrazeneca vaccine produced by the serum institute of India
By: (SKNIS), Press Release

    Basseterre, St. Kitts, September 24, 2021 (SKNIS): Persons from St. Kitts and Nevis who received a jab of the Oxford-AstraZeneca COVID-19 vaccine have been assured that their vaccination status will be recognized by international countries including the United States and the United Kingdom.

     

    Chief Medical Officer, Dr. Hazel Laws, gave the assurance during Wednesday’s COVID-19 Briefing by the National Emergency Operations Centre.

     

    “I want to assure the public that the United Kingdom recognizes the Oxford-AstraZeneca vaccine from the Serum Institute of India, that’s the Covishield, and I think they also recognize the SK Bioscience,” Dr. Laws said referencing the vaccine produced in South Korea.

     

    The rationale for the SK Bioscience manufactured vaccine is based on a list of approved countries that the UK has. Countries on the list also administered the same vaccine from South Korea.

     

    “The United Kingdom has sent us a number of questions regarding our vaccination programme, which we have answered, and in terms of St. Kitts and Nevis and our population travelling to the UK, within short order, we expect that St. Kitts and Nevis will be on that list whereby the vaccines administered locally will be accepted by other neighbouring islands,” Dr. Laws stated.

     

    Medical Chief of Staff of the Joseph N. France General Hospital, Dr. Cameron Wilkinson, added that he recently travelled to the United States and experienced no issues related to his COVID-19 jab.

     

    The United Kingdom revised its travel advisory on Wednesday 22nd September, to include the Covishield, the COVID-19 vaccine jointly developed by AstraZeneca and the Oxford University and manufactured by the Serum Institute of India. The UK said that the Covishield vaccine produced in India will qualify as an approved vaccine for travellers visiting Britain from any part of the world from October 4 onwards.
      

     

     

    Disclaimer

     

    This article was posted in its entirety as received by SKNVibes.com. This media house does not correct any spelling or grammatical error within press releases and commentaries. The views expressed therein are not necessarily those of SKNVibes.com, its sponsors or advertisers
     

     

Copyright © 2021 SKNVibes, Inc. All rights reserved.
Privacy Policy   Terms of Service